BBV154 News
Bharat Biotech has completed phase III clinical trials for intranasal Covid vaccine
The firm said that 'it has proven to be safe'
BBV154 has been specifically formulated to allow intranasal delivery
Bharat Biotech has received approval for phase 3 clinical trials of intranasal vaccine.
Intranasal vaccine can be easily administered.
Loading...